Search

Your search keyword '"MURINE CYTOMEGALOVIRUS"' showing total 40 results

Search Constraints

Start Over You searched for: Descriptor "MURINE CYTOMEGALOVIRUS" Remove constraint Descriptor: "MURINE CYTOMEGALOVIRUS" Topic cytomegalovirus diseases Remove constraint Topic: cytomegalovirus diseases
40 results on '"MURINE CYTOMEGALOVIRUS"'

Search Results

1. Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway.

2. Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination.

3. Membraneless Compartmentalization of Nuclear Assembly Sites during Murine Cytomegalovirus Infection.

4. Selective Inhibition of Murine Cytomegalovirus Viral Gene Expression by the Antiviral Peptide TAT-I24.

6. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.

7. Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells.

8. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.

9. Heart Dysfunction Following Long-Term Murine Cytomegalovirus Infection: Fibrosis, Hypertrophy, and Tachycardia.

10. Immunometabolic phenotype of BV-2 microglia cells upon murine cytomegalovirus infection.

11. Murine cytomegalovirus M72 promotes acute virus replication in vivo and is a substrate of the TRiC/CCT complex.

12. Host subspecific viral strains in European house mice: Murine cytomegalovirus in the Eastern (Mus musculus musculus) and Western house mouse (Mus musculus domesticus).

13. Landmarks of endosomal remodeling in the early phase of cytomegalovirus infection.

14. Expression pattern of CD11c on lung immune cells after disseminated murine cytomegalovirus infection.

15. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.

16. Difference in replication of low-passage MCMV HaNa1 in BALB/c, C57BL/6 and NOD mice and role of different branches of immunity in susceptibility.

17. Cochlear Spiral Ganglion Neuron Apoptosis in Neonatal Mice with Murine Cytomegalovirus-Induced Sensorineural Hearing Loss.

18. Infections of neonatal and adult mice with murine CMV HaNa1 strain upon oronasal inoculation: New insights in the pathogenesis of natural primary CMV infections.

19. Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus.

20. Spatial distribution and structural arrangement of a murine cytomegalovirus glycoprotein detected by SPDM localization microscopy.

21. Time-lapse ultrashort pulse microscopy of infection in three-dimensional versus two-dimensional culture environments reveals enhanced extra-chromosomal virus replication compartment formation.

22. Early Endosomal Retention of Murine Cytomegalovirus m06 Protein.

23. Recombinant murine cytomegalovirus vector activates human monocyte-derived dendritic cells in a NF-κB dependent pathway

24. nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro.

25. The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence.

26. Murine cytomegalovirus regulation of NKG2D ligands.

27. Quantitative investigation of murine cytomegalovirus nucleocapsid interaction.

28. A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection

29. Induction of early murine cytomegalovirus infection by different reporter gene-associated recombinant viruses.

30. Characterization and regulation of essential murine cytomegalovirus genes m142 and m143

31. Intranasal immunization with a replication-deficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity

32. The murine cytomegalovirus M73.5 gene, a member of a 3′ co-terminal alternatively spliced gene family, encodes the gp24 virion glycoprotein

33. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: Correlation with intraocular levels of tumor necrosis factor-α and interferon-γ.

34. AIDS-related cytomegalovirus retinitis: Lessons from the laboratory.

35. Experimental study on the prevention and treatment of murine cytomegalovirus hepatitis by using allitridin

36. Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity

37. Atypical cytomegalovirus retinal disease in pyroptosis-deficient mice with murine acquired immunodeficiency syndrome.

38. Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice.

39. MHC proteins and heparan sulphate proteoglycans regulate murine cytomegalovirus infection.

40. Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.

Catalog

Books, media, physical & digital resources